Cargando…

Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine

AIMS: Carbamazepine can cause hypersensitivity reactions in ~10% of patients. An immunogenic effect can be produced by the electrophilic 10,11‐epoxide metabolite but not by carbamazepine. Hypothetically, certain single nucleotide polymorphisms might increase the formation of immunogenic metabolites,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yip, Vincent L.M., Pertinez, Henry, Meng, Xiaoli, Maggs, James L., Carr, Daniel F., Park, B. Kevin, Marson, Anthony G., Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247401/ https://www.ncbi.nlm.nih.gov/pubmed/33217013 http://dx.doi.org/10.1111/bcp.14667

Ejemplares similares

The HLA-A*31:01 allele: influence on carbamazepine treatment
por: Yip, Vincent Lai Ming, et al.
Publicado: (2017)

Effect of esomeprazole on the pharmacokinetics of carbamazepine
por: Medhi, Bikash, et al.
Publicado: (2011)

Shared Genetic Risk Factors Across Carbamazepine‐Induced Hypersensitivity Reactions
por: Nicoletti, Paola, et al.
Publicado: (2019)

Markedly Elevated Carbamazepine-10,11-epoxide/Carbamazepine Ratio in a Fatal Carbamazepine Ingestion
por: Russell, Jason L., et al.
Publicado: (2015)

The Effect of Pioglitazone on Pharmacokinetics of Carbamazepine in Healthy Rabbits
por: Abushammala, Issam
Publicado: (2015)

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation
por: Song, Ivy, et al.
Publicado: (2016)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
por: Ngo, Lien Thi, et al.
Publicado: (2020)

Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects
por: David, Olivier J., et al.
Publicado: (2018)

Characterization of Drug-Specific CD4(+) T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2023)

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
por: Turner, Richard Myles, et al.
Publicado: (2019)

Population Pharmacokinetic and Pharmacogenetic Analysis of Nevirapine in Hypersensitive and Tolerant HIV-Infected Patients from Malawi
por: Dickinson, Laura, et al.
Publicado: (2014)

A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012
por: Tolou-Ghamari, Zahra, et al.
Publicado: (2013)

The relationship between pharmacokinetic parameters of carbamazepine and therapeutic response in epileptic patients
por: Chbili, Chahra, et al.
Publicado: (2016)

Liquid Enteral Nutrients Alter the Pharmacokinetics of Orally Administered Carbamazepine in Rats
por: Urashima, Yoko, et al.
Publicado: (2022)

New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity
por: Pirmohamed, Munir, et al.
Publicado: (2015)

Pharmacokinetic and pharmacodynamic drug interactions of carbamazepine and glibenclamide in healthy albino Wistar rats
por: Prashanth, S., et al.
Publicado: (2011)

Application of the Population Pharmacokinetics Model-Based Approach to the Prediction of Drug–Drug Interaction between Rivaroxaban and Carbamazepine in Humans
por: Ngo, Lien Thi, et al.
Publicado: (2023)

Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi
por: Dickinson, L, et al.
Publicado: (2010)

Non-Recurrence of Carbamazepine Induced Vitiligo after Rechallenge with Carbamazepine
por: Saeedloo, Masoomeh, et al.
Publicado: (2013)

Pharmacogenetics of CYP3A5 on Carbamazepine pharmacokinetics in epileptic patients developing toxicity
por: Al-Gahtany, Mubarak, et al.
Publicado: (2014)

Effects of semi-solidification of enteral nutrients on the pharmacokinetic behavior of orally administered carbamazepine in rats
por: Nagai, Katsuhito, et al.
Publicado: (2019)

A Pharmacokinetic Evaluation of a Pectin-Based Oral Multiparticulate Matrix Carrier of Carbamazepine
por: Amponsah, Seth Kwabena, et al.
Publicado: (2021)

Teratogenic Effects of Carbamazepine in Mice
por: Jose, Manna, et al.
Publicado: (2017)

Pharmacodynamic and pharmacokinetic interaction of Panchagavya Ghrita with phenytoin and carbamazepine in maximal electroshock induced seizures in rats
por: Joshi, Rupa, et al.
Publicado: (2015)

Personalizing carbamazepine therapy
por: Mushiroda, Taisei, et al.
Publicado: (2011)

Membranous nephropathy and carbamazepine
por: Sangeetha, B., et al.
Publicado: (2014)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Carbamazepine-induced angioedema
por: Subramanian, Ansha, et al.
Publicado: (2016)

Acute Carbamazepine Intoxication
por: Gallego, María Dolores Calabria, et al.
Publicado: (2022)

Epilepsy control with carbamazepine monotherapy from a genetic perspective
por: Ullah, Shakir, et al.
Publicado: (2018)

Genome-wide association study of nevirapine hypersensitivity in a malawian HIV-infected population
por: Carr, Daniel, et al.
Publicado: (2014)

Pharmacogenomics: Current State-of-the-Art
por: Carr, Daniel F., et al.
Publicado: (2014)

Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug–drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine
por: Ngo, Lien Thi, et al.
Publicado: (2022)

A Review of the Important Role of CYP2D6 in Pharmacogenomics
por: Taylor, Christopher, et al.
Publicado: (2020)

CYP2B6*18 is associated with nevirpine hypersensitivity independently of HLA-C*04:01 in a Malawian HIV population
por: Carr, Daniel, et al.
Publicado: (2014)

CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Corrigendum: CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Favorable response to carbamazepine therapy in genetically proven myoclonus-dystonia child
por: Aljabri, Mohammed F., et al.
Publicado: (2021)

Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study
por: Pohlmann-Eden, Bernd, et al.
Publicado: (2016)

Carbamazepine and Electro Convulsive Threshold
por: Goswami, Utpal, et al.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_glcnp9igc0rk88aci6m8o3o2sb